期刊名称：OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
| Ophthalmic Plastic and Reconstructive Surgery features original articles and reviews on topics such as ptosis, eyelid reconstruction, orbital diagnosis and surgery, lacrimal problems, and eyelid malposition. Update reports on diagnostic techniques, surgical equipment and instrumentation, and medical therapies are included, as well as detailed analyses of recent research findings and their clinical applications. | |
|
Instructions to Authors
Ophthalmic Plastic and Reconstructive Surgery (OPRS) publishes Original Articles describing clinical and laboratory investigations, Brief Reports, and, by invitation, Editorials, Perspectives, and Reviews. The journal is owned and sponsored by the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) but welcomes submissions from authors who are not members of the Society.
OPRS encourages submission of digital manuscript and image files to expedite the review process. Reduced pricing for digitally submitted color images ($100/file) applies to images prepared according to the publisher's guidelines. See Submission of Digital Text and Image Files for file preparation and submission details.
GENERAL INFORMATION AND POLICIES
OPRS subscribes to the policies outlined in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” written by the International Committee of Medical Journal Editors (N Engl J Med 1991;324:424–8).
Authorship. OPRS expects each author to have made a significant intellectual contribution to the design or execution of the project, to the writing of the manuscript, or both. Each author must take full responsibility for his or her contribution and must have approved the final manuscript. (Lundberg GD, Glass RM. What does authorship mean in a peer-reviewed medical journal? [editorial] JAMA 1996;276:75.)
Papers from the ASOPRS Annual Scientific Symposium. OPRS holds copyright and has the right of first refusal for all manuscripts derived from papers presented at the Annual Scientific Symposium of the American Society of Ophthalmic Plastic and Reconstructive Surgery. Permission to submit such work elsewhere must be sought from the Editor. Presenters who violate this policy will be excluded by the Program Committee from participation in the Annual Scientific Symposium for two years.
Acknowledgments. OPRS does not print acknowledgments for persons who provided collegial support to the authors; for those who reviewed, discussed, edited, or typed a manuscript; or for individuals who, by performing remunerated work, contributed to the implementation of the study, e.g., secretaries, clinic coordinators, technicians, ophthalmic photographers, or technologists. At the request of the author and the discretion of the Editor, OPRS may acknowledge those who referred patients, translated references, provided extensive statistical assistance, or provided essential tissue, equipment, or other materials without which the study could not have been completed. (The Author Wishes to Thank . . . [editorial]. Ophthalmology 1988;95:293–4.)
Commercial Interests. Each author must disclose in a cover letter to the Editor any individual or family investments, stock ownership exceeding 1% of a company's worth, consulting, retainers, patents, or other commercial interests that could cause or be perceived to be a conflict of interest. Mutual funds, retirement accounts, and so forth need not be mentioned. Such disclosure will not affect the review of the manuscript. A statement that no such conflicting relationship exists is encouraged, when appropriate, on the title page if any commercial connection between the authors and the topic may be suspected.
Prior and Repetitive Publication. OPRS will not consider manuscripts that have appeared in part or in total in other publications, except in special circumstances by approval of the Editor. Updates of previously published studies that add little data to an existing publication will not be considered. Overlap between patient groups described in serial manuscripts must be acknowledged, and references to previous publications that include the same patients must be provided. Authors uncertain as to whether specific data represent prior or repetitive publication should alert the Editor in the transmittal letter and include copies of the publication(s) in question.
Precedence. Because some widely read publications currently are not included in computerized databases, authors who claim precedence for an idea, observation, or therapy are advised to review existing published reports (including textbooks) thoroughly and to include an appropriate disclaimer, e.g., “We were unable to find any previous report of this” or “As far as we are aware, this has not been previously reported.”
Rejection by Other Journals. Rejection of a manuscript by another journal will not compromise a review by OPRS. Authors are encouraged to inform the Editor if the manuscript has been rejected previously and to include copies of the review and author responses.
Informed Consent. Manuscripts reporting the results of experimental investigation on humans must include a statement that informed consent was obtained and that the appropriate institutional committee or review board (IRB) approved the protocol, or that IRB approval was not required for the study.
Animal Studies. If animals were used in a study, the manuscript should include the appropriate IRB approval statement.
Statistical Analysis. OPRS strongly advises statistical consultation about data collection and analysis. Statistical methods must be identified in table footnotes, illustration legends, or text explanations. Software programs used for complex statistical analyses must be identified to enable reviewers to verify calculations.
Ocular Trauma Terminology. Terminology used in descriptions of ocular trauma should conform to the recommendations of the United States Eye Injury Registry and the International Society of Ocular Trauma (Birmingham Eye Trauma Terminology [BETT], Kuhn F, Morris R, Witherspoon D, et al. A standardized classification of ocular trauma. Ophthalmology 1996;103:240–3).
MANUSCRIPT PREPARATION, SUBMISSION, REVIEW, REVISION, AND PUBLICATION
Manuscripts should be double spaced on one side only of 8.5 * 11-inch white paper. The right margin should not be justified. The components of the manuscript are as follows.
Original Articles: In general, submissions should not exceed eight journal pages (1 journal page = 3 double-spaced typewritten pages, or four figures, or two tables).
Brief Reports (including Single Case reports, Photoessays, and Clinicopathologic Reports): Please limit the submission to 750 words, three figures or tables, and six references, or two journal pages, using the above conversion.
Letters to the Editor should not exceed 500 words, and may include up to two figures or tables and four references.
Title Page. The title page should include the following information:
1. Title—meaningful and as brief as possible. No longer than 135 characters. Declarative titles should not be used.
2. Names of authors—provide first name, middle initial, last name, advanced degrees, and professional certification. The Journal does not print society affiliations (such as the American College of Surgeons).
3. Institutional affiliation—indicate each author's affiliation during the course of the study in footnotes on the title page using superscript numbers, not symbols (e.g., John Doe1).
4. Meeting presentation—if the material has been presented previously, supply the name, place, and date of the meeting.
5. Financial support—identify all sources, public and private. Provide the agency name and city, company name and city, fellowship name, and grant number.
6. Proprietary interest statement—see Commercial Interests. Each author is expected to disclose any type of financial interest that is related to the manuscript, including stock or ownership of a business entity connected to a product described in the paper, paid consulting for the company or competing companies, or patent rights to a drug or piece of equipment. Authors must disclose personal or family ownership or potential rights to more than 1% of the company or competing company and whether they have any interest in marketing any product, drug, instrument, or piece of equipment discussed in the manuscript.
7. Running head—no longer than 60 characters.
8. Address for reprints if they will be available.
Précis. On a separate page (page 2), each manuscript must include a one-sentence précis (35 words or fewer) summarizing the main finding or outcome of the study. The précis should not simply duplicate the abstract conclusion. Papers will not be sent for review if unaccompanied by a précis. If the paper is published, the précis will appear under the title in the Table of Contents.
Structured Abstract. Each manuscript must include a structured abstract of ≤250 words (except for Brief Reports; see below). The abstract must appear on a separate page (page 3) and should include four separate sections: Purpose, Methods, Results, and Conclusions. Manuscripts without the required structured abstract will not be reviewed until the required abstract is received.
Structured Abstract Section Definitions.
Purpose: Provide a concise statement of the study goal (e.g., the question to be answered or the hypothesis to be tested).
Methods: Identify the study design using a phrase such as randomized or nonrandomized clinical trial, case-controlled study, cross-sectional study, cohort study, case series, case report, metaanalysis, review, experimental study, or historical manuscript. Definitions of study design terms and recommended modifiers (retrospective, prospective, observational, interventional, etc.) are listed in a helpful appendix Glossary in the Home Page for the journal Ophthalmology (www.eyenet.org/ophthalmology). Patient selection, interventions, and outcome measures must be defined.
Results: Briefly summarize the principal measurements (data) obtained and relevant statistical analysis.
Conclusions: State the specific conclusion(s) derived from the data analysis and its (their) clinical significance.
Abstract for Brief Reports. Provide a brief summary of the report (≤150 words). The abstract should appear on a separate page following the précis.
Text. All manuscripts must follow generally recognized standards for presenting scientific material. See CBE Style Manual, 6th ed. (Council of Biology Editors; 1995). Type size (True Type fonts) should be 12 point. The Introduction, without a heading, should refer only to the most pertinent past publications and should not be an extensive review of the literature. Materials and Methods should be written with sufficient detail to permit others to duplicate the work. Results must be concise and not simply a reiteration of data presented in Tables. Discussion should be restricted to the significant findings presented. Digressions and speculation are not appropriate.
References. References should follow text and begin on a separate page. They must be double spaced and numbered consecutively in order of appearance in the text. References should be designated by superscript numbers following all punctuation (except semicolons and colons).
1. List only references that you have read and that are pertinent to the manuscript.
2. Cite only published studies as references. You may acknowledge “unpublished data” or “submitted” articles within parentheses in the text. Reference to a “personal communication” within parentheses in the text must be accompanied by a signed permission letter from the individual being cited.
3. Abstracts such as those published in the annual meeting programs of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), the American Academy of Ophthalmology (AAO), or the Association for Research in Vision and Ophthalmology (ARVO) are considered “unpublished” and should be cited in parentheses in the text. For example:—by Smith et al. (Invest Ophthalmol Vis Sci 28 (Suppl):54, 1989).
4. Oral or poster presentations are similarly unpublished and may be cited only in parentheses in the text. Platform and poster presentations at annual meetings are customarily indicated: (Smith AB, presented at the AAO Annual Meeting, Atlanta, 1995).
5. Books or articles “in press” may be cited as numbered references. Such citations should be updated before publication, if pertinent.
Journal abbreviations should be those used by the National Library of Medicine, as found in Index Medicus. If in doubt as to the correct abbreviation, cite the complete journal name. Do not underline journal titles, and do not use periods in abbreviations of journal titles or in author initials. Please follow precisely the format and punctuation shown in the following examples.
Journal Article—(If four or fewer authors, list all) Anderson RL, Beard C. The levator aponeurosis: attachments and their clinical significance. Arch Ophthalmol 1977;95:1437–41.
Journal Article—(If five or more authors, list only the first three and add et al) Meyer DR, Bui HX, Carlson JA, et al. Silicon granulomas and dermatomyositis-like changes associated with chronic eyelid edema after silicone breast implant. Ophthal Plast Reconstr Surg 1998;14:182–8.
Chapter in a Book—Kaltreider SA, Sherman DD, McGetrick JJ. Eyelid trauma. In: Dortzbach RK, ed. Ophthalmic plastic surgery: prevention and management of complications. New York: Raven Press, 1994:157–74.
Book—Miller NR. Walsh and Hoyt's clinical neuro-ophthalmology. 4th ed. Vol. 4. Baltimore: Williams & Wilkins; 1991;2102–14.
Letter to the Editor—Sneed SR, Blodi CF, Berger BB, et al. Pneumocystis carinii choroiditis in patients receiving inhaled pentamidine [letter]. N Engl J Med 1990;322:936–7.
Paper From a Meeting—Eisenberg J. Market forces and physician workplace reform: why they may not work. Paper presented at: Annual Meeting of the Association of American Medical Colleges; October 17–21; Washington, DC.
On-line Journal Article—LaPorte RE, Marler E, Akazawa S, Sauer F. The death of biomedical journals. JAMA [serial online]. 1996;310:1387–90. Available at http://www.jama.com/jama/archive/6991ed2.htm. Accessed June 16, 1997.
World Wide Web Site—Health Care Financing Administration. 1996 statistics at a glance. Available at: http://www.hcfa.gov/stats/stathili.htm. Accessed December 2, 1997.
Tables. Tables should follow references. Each table must be numbered consecutively using Arabic numbers, be mentioned in the text, and be titled. Each column must have a heading. All abbreviations must be explained in the legend. Please do not type more than one table per page.
Legends. Figure legends (photos, drawings, graphs) should follow tables. Figures must be numbered consecutively as they appear in the text. For histologic figures, stains and magnifications should be noted in the legend. Any figure that has been published elsewhere should have an acknowledgment to the original source; a copy of the release to publish the figure, signed by the copyright holder, must also be submitted. Legends must identify all symbols or letters that appear on the prints.
Abbreviations. Restrict abbreviations to those that are widely used and understood. Avoid abbreviations that have meaning only in the context of your specific manuscript. An abbreviation should appear first in parentheses immediately after the term or phrase to which it refers. Abbreviations may only be used if the term appears five or more times in the text. Abbreviations are not used in abstracts.
Drug/Manufacturer Names. Use generic names only in the text body. Include the trade name of a particular drug and the manufacturer’s name and location, cited in parentheses, after the first use of the generic name. In the case of equipment, include manufacturer’s name, city, state, and/or country.
Illustrations. Submit three identical complete sets of prints in three separate envelopes, noting which copy should go to the printer. High-quality laser copies of color prints may be substituted if necessary to reduce expense. Each print (or copy) must be separately labeled with the author’s name, figure number, and an indication (arrow) as to orientation (up). Put all information on a separate label on the back of the illustration to avoid writing on or damage to the prints. Color prints should be accompanied by original 35mm slides. Slides must be in protective jackets and numbered identically to prints. Write “front” and “top” on front of slide only. Orientation must match the prints. Clinical photographs should be masked when possible to prevent identification of the patient. Clinical photographs that permit identification of an individual must be accompanied by a signed statement by the patient or guardian granting permission for publication of the pictures for educational purposes. Prints of illustrations (e.g., clinical photographs, fluorescein angiography, computed tomographic scans, magnetic resonance imaging scans, radiographs, photomicrographs, data tables, graphs) must be large enough to be read easily (preferably 5 × 7 inches). Prints must not exceed 8 × 10 inches.
Number of Copies. Three complete copies of the manuscript and accompanying illustrations or pictures must be submitted. One copy of the manuscript and illustrations should be designated as the “original.”
Transmittal Letter. Each submission must be accompanied by a letter to the Editor. The transmittal letter must identify the corresponding author, list any meetings where the material is under consideration for presentation or has been previously presented, and disclose any conflict of interest (see Commercial Interests and Prior and Repetitive Publication). The transmittal letter must include a copyright transfer. The editorial office must be supplied with phone and fax numbers for the corresponding author. E-mail addresses, if available, should also be provided. The editorial office must be notified by phone, fax, or e-mail of any changes in the order of authorship, author name change, or address or phone number of the corresponding author. Always indicate the manuscript number in subsequent communications or correspondence.
Copyright. Consideration of manuscripts for publication in Ophthalmic Plastic and Reconstructive Surgery is dependent on the assurance that the material (in whole or part) is not under consideration by another journal, is not in press in any other format, and has not been previously published. Each author must sign a statement transferring copyright ownership to the American Society of Ophthalmic Plastic and Reconstructive Surgery. Authors may request a copyright transfer form from the OPRS editorial office or, alternatively, the following statement, signed by each author, may accompany the manuscript transmittal letter:
In consideration of the journal, Ophthalmic Plastic and Reconstructive Surgery, taking action in reviewing and editing my (our) manuscript, the author(s) undersigned hereby transfers, assigns, or otherwise conveys all copyright ownership to the American Society of Ophthalmic Plastic and Reconstructive Surgery in the event that such work is published in Ophthalmic Plastic and Reconstructive Surgery. Such conveyance covers any product that may derive from the published journal, whether print or electronic.
Some authors who work for the federal government may be required to sign the following statement:
The above-named article is a work of authorship prepared as part of the undersigned author's (authors') official duties as an officer or employee of the United States government and is therefore in the public domain. Should, however, the article ever be determined to be copyrightable, I (we) hereby transfer, assign, or otherwise convey all copyright ownership in the above-named article to the American Society of Ophthalmic Plastic and Reconstructive Surgery.
Receipt of Manuscript, Review Process, and Revisions. Each manuscript will be acknowledged in the order received in the OPRS office. The acknowledgment letter will note the number assigned to the manuscript; this number should be referenced during all subsequent communications about the manuscript. OPRS does not reveal the identity of its reviewers but does provide pertinent comments to the corresponding author. Usually two and sometimes several reviewers will participate in the review of a manuscript. Re-review may be required after revision if, in the judgment of the Editor, sufficient modification of the manuscript or data justifies another review cycle. Revisions must be returned to the Editor within four months or the manuscript will be deaccessioned.
Publication Process. The corresponding author receives typeset page proofs and the copyedited manuscript. Each author is expected to proofread all pages carefully and answer all queries posed by the copy editor. All page proofs must be returned to the publisher within 72 hours of receipt to avoid delay in publication.
Reprints. A reprint order form will accompany your copyedited manuscript and page proofs. You must return this form with your corrected page proofs, whether or not you order reprints. The cost of reprints increases significantly if they are ordered after the initial print run. Reprints, except special orders of 100 or more, are available only from authors.
Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by the American Society of Ophthalmic Plastic and Reconstructive Surgery. (This applies to libraries and others registered with the Copyright Clearance Center (CCC) Transactional Reporting Service, provided that the base fee of $10.00 is paid directly to CCC, 222 Rosewood Drive, Danvers, MA 01923.)
AUTHOR’S CHECKLIST
- Three copies of manuscript and three sets of illustrations. Manuscript double spaced, including references; pages numbered; all illustrations labeled.
- A diskette containing the manuscript text and a separate disk containing the image files.
- Copyright release signed by all authors.
- Transmittal letter to Editor with appropriate conflict of interest (disclosure) statement and complete address of corresponding author, including current phone, fax, and e-mail information.
- Proper title page, précis page, and complete structured abstract (summary for Brief Reports).
- Permission forms for any previously published illustrations.
- Appropriate IRB statement in text.
- Appropriate acknowledgment of sponsors and grants.
Manuscripts will not be accessioned and sent for review until all required items are received.
Gerald J. Harris, M.D.
Editor, Ophthalmic Plastic and Reconstructive Surgery
Eye Institute
Medical College of Wisconsin
925 N. 87th Street
Milwaukee, WI 53226 U.S.A.
Telephone: 414-456-7872
Fax: 414-456-6300
E-mail: OPRS@mcw.edu
SUBMISSION OF DIGITAL TEXT AND IMAGE FILES
- Follow the guidelines for manuscript preparation, using MS Word. Send a diskette containing the MS Word file for your submission, along with three copies of the manuscript, three sets of laser prints (color laser for color images), a cover letter, and a signed copyright assignment form.
- Submit a separate CD-ROM containing the image files. The publisher's discounted cost to authors is $100 per file for images in TIFF or EPS format. For the peer review process, lower-resolution JPEG files are required.
- Please follow these guidelines carefully. Image manipulation by the printer will substantially increase the cost to authors.
- Save black-and-white images in B/W mode and color images in CMYK mode, in TIFF or EPS format. Figures must not be embedded in a layout format (e.g., Quark). Submit a separate file for each figure. Recommended resolutions: 300 dpi for halftones, 600 dpi for combination halftones, and 1200 dpi for line art. Images (single or composite) should be submitted in the sizes at which they will be printed, and must not exceed 3.5 inches (one column) in width.
- For more information about digital artwork guidelines, please visit the printer's Web site: http://cpc.cadmus.com/da/. The cost of color illustrations is charged to the author by the publisher, and an estimate of the cost is provided once production has been scheduled. Manipulation charges, at an hourly rate, will be applied for changing of a figure's color mode from RGB to CMYK or doing substantial re-sizing and/or cropping.
- Save a copy of each image as a lower-resolution (no greater than 100 dpi) JPEG file on the same CD-ROM.
Editorial Board
|
Manuscripts should be sent to:
Gerald J. Harris, M.D.
Eye Institute
Medical College of Wisconsin
925 N. 87th Street
Milwaukee, WI 53226
Tel: 414-456-7872
FAX: 414-456-6300
E-mail: OPRS@mcw.edu |
| 
刊名字顺( Alphabetical List of Journals):
返回页首 